As of 2025-07-15, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 1.34 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.93 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -54.3%.
The range of the Relative Valuation is 1.13 - 1.82 CAD.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 21.5x | 16.3x |
| Forward P/E multiples | 16.0x - 19.0x | 16.1x |
| Fair Price | 1.13 - 1.82 | 1.34 |
| Upside | -61.5% - -37.8% | -54.3% |
| Date | P/E |
| 2025-07-11 | 42.07 |
| 2025-07-10 | 43.93 |
| 2025-07-09 | 42.50 |
| 2025-07-08 | 43.21 |
| 2025-07-07 | 43.21 |
| 2025-07-04 | 44.65 |
| 2025-07-03 | 43.50 |
| 2025-07-02 | 44.94 |
| 2025-06-30 | 45.51 |
| 2025-06-27 | 45.22 |
| 2025-06-26 | 45.22 |
| 2025-06-25 | 48.10 |
| 2025-06-24 | 47.09 |
| 2025-06-23 | 48.81 |
| 2025-06-20 | 46.23 |
| 2025-06-19 | 45.51 |
| 2025-06-18 | 44.36 |
| 2025-06-17 | 43.50 |
| 2025-06-16 | 43.07 |
| 2025-06-13 | 42.07 |
| 2025-06-12 | 42.07 |
| 2025-06-11 | 42.35 |
| 2025-06-10 | 41.06 |
| 2025-06-09 | 40.77 |
| 2025-06-06 | 40.77 |
| 2025-06-05 | 41.64 |
| 2025-06-04 | 41.64 |
| 2025-06-03 | 42.50 |
| 2025-06-02 | 42.07 |
| 2025-05-30 | 44.22 |
| 2025-05-29 | 41.35 |
| 2025-05-28 | 41.49 |
| 2025-05-27 | 41.92 |
| 2025-05-26 | 42.21 |
| 2025-05-23 | 39.48 |
| 2025-05-22 | 39.05 |
| 2025-05-21 | 37.90 |
| 2025-05-20 | 37.04 |
| 2025-05-16 | 38.62 |
| 2025-05-15 | 38.62 |
| 2025-05-14 | 35.89 |
| 2025-05-13 | 37.18 |
| 2025-05-12 | 39.19 |
| 2025-05-09 | 41.92 |
| 2025-05-08 | 40.63 |
| 2025-05-07 | 37.18 |
| 2025-05-06 | 38.05 |
| 2025-05-05 | 38.91 |
| 2025-05-02 | 39.63 |
| 2025-05-01 | 40.20 |